antibody

Human Myeloma IgA1 kappa

MBS318189

5 mg

315 USD

monoclonal

human

nonconjugated

Antibody

Human Myeloma IgA1 kappa

IgA1, kappa

Human Myeloma Plasma

IgA1, kappa

>95% pure (SDS-PAGE)

Purified, Liquid

2.81 mg/ml (OD280 nm, E1% = 13.4)

Upon receipt, aliquot and store at -20 degree C. Avoid multiple freeze/thaw cycles.

IEP

Specific methodologies have not been tested using this product.

Inactivation: Not applicable.

Buffer: 10mM Sodium phosphate, pH 7.4 containing 150mM Sodium chloride. Preservative: 0.05% Sodium azide. Dry Ice Shipment: Extra charge fee may add to your shipping cost as dry ice is required to ship this product. Warnings: This product contains sodium azide, which has been classified as Xn (Harmful), in European Directive 67/548/EEC in the concentration range of 0.1 - 1.0%. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains. All donor units tested negative for HIV1 and HIV2 and non-reactive for HBsAg, anti-HCV and anti-HBc. Because no test can guarantee a sample to be non-infectious, all material derived from human fluids or tissues should be considered as potentially infectious.

Purified Human Immunoglobulins

Human Myeloma IgA1, Kappa; Human Immunoglobulin A1, kappa (IgA1, kappa). Single arc by IEP against antisera to whole human serum, IgA1, and human kappa. No reaction by IEP against human IgA2, IgG, IgM, IgD, IgE, and lambda.

5 mg

315 USD